Published in F1000 Med Rep on October 12, 2010
Inhaled anticholinergic use and all-cause mortality among elderly Medicare beneficiaries with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2013) 0.76
Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet (1997) 44.03
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med (2001) 27.83
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med (2007) 19.86
A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med (2008) 17.19
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J (2004) 16.84
A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med (2003) 10.40
Global burden of COPD: risk factors, prevalence, and future trends. Lancet (2007) 9.50
Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med (2008) 6.17
Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med (2007) 5.51
Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins. Chest (2007) 4.96
Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Intern Med (1980) 4.81
Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2006) 4.80
Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl J Med (1999) 4.65
Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax (2003) 4.02
Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial. Lancet (1999) 3.90
Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J (2006) 3.89
Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet (2000) 3.68
Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study. Lancet (2008) 3.62
Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2009) 3.61
COPD exacerbations .1: Epidemiology. Thorax (2006) 2.94
Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol (2005) 2.92
The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients. Eur Respir J (2002) 2.84
Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease. Arch Intern Med (2010) 2.82
Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations. Am J Respir Crit Care Med (2008) 2.66
Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2009) 2.55
Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. Respir Med (2006) 2.29
The coordination of breathing and swallowing in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2009) 2.23
Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study. Chest (2009) 2.20
Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest (2009) 2.16
Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results. Eur Respir J (2009) 2.11
Meta-analyses on suspected chronic obstructive pulmonary disease genes: a summary of 20 years' research. Am J Respir Crit Care Med (2009) 2.04
Bronchodilator response in chronic obstructive pulmonary disease. Am Rev Respir Dis (1986) 1.87
Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis. Arch Intern Med (2009) 1.86
Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2007) 1.82
Impact of noninvasive home ventilation on long-term survival in chronic hypercapnic COPD: a prospective observational study. Int J Clin Pract (2007) 1.65
Vitamin D beyond bones in chronic obstructive pulmonary disease: time to act. Am J Respir Crit Care Med (2009) 1.63
Role of the parasympathetic system in airway obstruction due to emphysema. N Engl J Med (1984) 1.54
The genetics of chronic obstructive pulmonary disease. Respir Res (2001) 1.33
Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort. Thorax (2008) 1.29
Trends in hospitalization with chronic obstructive pulmonary disease-United States, 1990-2005. COPD (2010) 1.26
Abnormal swallowing reflex and COPD exacerbations. Chest (2009) 1.22
Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort study. Int J Clin Pract (2008) 1.20
Tiotropium and risk for fatal and nonfatal cardiovascular events in patients with chronic obstructive pulmonary disease: systematic review with meta-analysis. Respir Med (2009) 1.15
Trends in mortality from COPD in selected U.S. States differing in tobacco control efforts. COPD (2010) 1.09
Which spirometric indices best predict subsequent death from chronic obstructive pulmonary disease? Thorax (2000) 0.93
Oral immunotherapy with inactivated nontypeable Haemophilus influenzae reduces severity of acute exacerbations in severe COPD. Chest (2009) 0.92
The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med (2003) 32.30
International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet (2007) 10.12
The effect of age on the development and outcome of adult sepsis. Crit Care Med (2006) 4.08
Gender and chronic obstructive pulmonary disease: why it matters. Am J Respir Crit Care Med (2007) 2.80
Pulmonary embolism mortality in the United States, 1979-1998: an analysis using multiple-cause mortality data. Arch Intern Med (2003) 2.64
The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med (2009) 2.60
Race and gender differences in acute respiratory distress syndrome deaths in the United States: an analysis of multiple-cause mortality data (1979- 1996). Crit Care Med (2002) 2.52
Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest (2005) 2.41
Do insomnia complaints cause hypertension or cardiovascular disease? J Clin Sleep Med (2007) 2.24
The role of infection and comorbidity: Factors that influence disparities in sepsis. Crit Care Med (2006) 2.21
Does insomnia kill? Sleep (2005) 2.08
COPD surveillance--United States, 1999-2011. Chest (2013) 1.92
The epidemiology of sepsis in patients with malignancy. Chest (2006) 1.87
Worldwide patterns of bronchodilator responsiveness: results from the Burden of Obstructive Lung Disease study. Thorax (2012) 1.82
Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD. Am J Med (2009) 1.70
Prospective association between lung function and the incidence of diabetes: findings from the National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Diabetes Care (2004) 1.69
Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey. Chest (2003) 1.68
Self-reported asthma and health-related quality of life: findings from the behavioral risk factor surveillance system. Chest (2003) 1.67
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2015) 1.63
Life expectancy and years of life lost in chronic obstructive pulmonary disease: findings from the NHANES III Follow-up Study. Int J Chron Obstruct Pulmon Dis (2009) 1.57
Asthma and influenza vaccination: findings from the 1999-2001 National Health Interview Surveys. Chest (2003) 1.57
Leisure-time physical activity patterns among US adults with asthma. Chest (2003) 1.52
Cardiorespiratory hospitalizations associated with smoke exposure during the 1997, Southeast Asian forest fires. Int J Hyg Environ Health (2005) 1.46
C-reactive protein concentration distribution among US children and young adults: findings from the National Health and Nutrition Examination Survey, 1999-2000. Clin Chem (2003) 1.42
Country of birth as a risk factor for asthma among Mexican Americans. Am J Respir Crit Care Med (2004) 1.35
Predicting risk of airflow obstruction in primary care: Validation of the lung function questionnaire (LFQ). Respir Med (2010) 1.33
Incidence and cost of pneumonia in medicare beneficiaries. Chest (2012) 1.29
Asthma prevalence among US adults, 1998-2000: role of Puerto Rican ethnicity and behavioral and geographic factors. Am J Public Health (2006) 1.26
What is the cost to employers of direct medical care for chronic obstructive pulmonary disease? COPD (2006) 1.25
National vehicle emissions policies and practices and declining US carbon monoxide-related mortality. JAMA (2002) 1.23
Lung function impairment, COPD hospitalisations and subsequent mortality. Thorax (2011) 1.22
COPD and gender differences: an update. Transl Res (2013) 1.19
Determinants of quality of life among people with asthma: findings from the Behavioral Risk Factor Surveillance System. J Asthma (2004) 1.13
Economic Burden of COPD in the Presence of Comorbidities. Chest (2015) 1.11
Asthma, chronic obstructive pulmonary disease, and mortality in the U.S. population. COPD (2011) 1.08
Relationship between asthma, overweight, and physical activity among U.S. high school students. J Community Health (2006) 1.08
COPD prevalence in southeastern Kentucky: the burden of lung disease study. Chest (2008) 1.07
The role of body mass index and diabetes in the development of acute organ failure and subsequent mortality in an observational cohort. Crit Care (2006) 1.07
Development of the Lung Function Questionnaire (LFQ) to identify airflow obstruction. Int J Chron Obstruct Pulmon Dis (2010) 1.07
Chronic obstructive pulmonary disease and asthma-patient characteristics and health impairment. COPD (2013) 1.06
Airway obstructive diseases in older adults: from detection to treatment. J Allergy Clin Immunol (2010) 1.06
Trends in hospitalizations for AIDS-associated Pneumocystis jirovecii Pneumonia in the United States (1986 to 2005). Chest (2009) 1.06
Population distribution of high-sensitivity C-reactive protein among US men: findings from National Health and Nutrition Examination Survey 1999-2000. Clin Chem (2003) 1.05
Questionnaires and pocket spirometers provide an alternative approach for COPD screening in the general population. Chest (2012) 1.04
Alcohol intake is associated with altered pulmonary function. Alcohol (2005) 1.02
Prevalence of airway obstruction assessed by lung function questionnaire. Mayo Clin Proc (2011) 1.01
Exposure to indoor biomass fuel pollutants and asthma prevalence in Southeastern Kentucky: results from the Burden of Lung Disease (BOLD) study. J Asthma (2010) 0.99
Characteristics of adults dying with COPD. Chest (2002) 0.99
Sex differences in COPD and lung cancer mortality trends--United States, 1968-1999. J Womens Health (Larchmt) (2004) 0.99
Tobacco and other drug use among high school students with asthma. J Adolesc Health (2006) 0.99
Forced expiratory volume in 1 second and physical activity in the general population. Am J Med (2004) 0.99
Asthma phenotypes, risk factors, and measures of severity in a national sample of US children. Pediatrics (2005) 0.98
Incidence and cost of CAP in a large working-age population. Am J Manag Care (2012) 0.97
Dietary intake, physical activity, body mass index, and childhood asthma in the Third National Health And Nutrition Survey (NHANES III). Pediatr Pulmonol (2004) 0.97
Time trends in obesity among adults with asthma in the United States: findings from three national surveys. J Asthma (2005) 0.96
Hospitalization for patients with sarcoidosis: 1979-2000. Sarcoidosis Vasc Diffuse Lung Dis (2006) 0.95
Walking abnormalities are associated with COPD: An investigation of the NHANES III dataset. Respir Med (2010) 0.93
Fibrinogen, chronic obstructive pulmonary disease (COPD) and outcomes in two United States cohorts. Int J Chron Obstruct Pulmon Dis (2012) 0.92
Association of smoking and chronic pain syndromes in Kentucky women. J Pain (2011) 0.90
Lung disease and asthma severity in adults with asthma: data from the Third National Health and Nutrition Examination. J Asthma (2005) 0.90
Serum carotenoid concentrations in US children and adolescents. Am J Clin Nutr (2002) 0.90
Prescription practices for chronic obstructive pulmonary disease: findings from the national ambulatory medical care survey 1999-2010. COPD (2014) 0.89
Occupational chronic obstructive pulmonary disease: an update. Clin Chest Med (2012) 0.88
Outcomes of severe COPD exacerbations requiring hospitalization. Semin Respir Crit Care Med (2010) 0.87
The association of adverse pregnancy events and cardiovascular disease in women 50 years of age and older. J Womens Health (Larchmt) (2011) 0.86
Fewer hospitalizations for chronic obstructive pulmonary disease in communities with smoke-free public policies. Am J Public Health (2014) 0.85
Tobacco use: a chronic illness? J Community Health (2010) 0.83
Health-related quality of life and chronic obstructive pulmonary disease in North Carolina. N Am J Med Sci (2010) 0.82
Subjects with Discordant Airways Obstruction: Lost between Spirometric Definitions of COPD. Pulm Med (2011) 0.82
Coexisting asthma and COPD: confused clinicians or poor prognosticator? Chest (2008) 0.82
The role of income in reducing racial and ethnic disparities in emergency room and urgent care center visits for asthma-United States, 2001-2009. J Asthma (2011) 0.81
ADRB2 Arg16Gly polymorphism, lung function, and mortality: results from the Atherosclerosis Risk in Communities study. PLoS One (2007) 0.81
Women and chronic obstructive pulmonary disease: does sex influence survival? Am J Respir Crit Care Med (2006) 0.81
Race-ethnicity as an effect modifier of the association between HbAlc and mortality in U.S. adults without diagnosed diabetes. Eur J Endocrinol (2011) 0.81
Significant bronchodilator responsiveness and "reversibility" in a population sample. COPD (2010) 0.80
Serum antioxidant concentrations among U.S. adults with self-reported asthma. J Asthma (2004) 0.79
The effect of sex on asthma control from the National Asthma Survey. J Allergy Clin Immunol (2009) 0.79
COPD and lung cancer have come a long way ...baby. Am J Respir Crit Care Med (2007) 0.79
GOLD stage 0 COPD: is it real? Does it matter? Chest (2006) 0.79
Counting costs in COPD: what do the numbers mean? Chest (2015) 0.79
Doc, my asthma (depression) has gotten me down (wheezing). Chest (2008) 0.79
Regional differences in hospitalizations for asthma in the United States, 1988-1996. J Asthma (2002) 0.79
Gender specific differences in the pros and cons of smoking among current smokers in Eastern Kentucky: implications for future smoking cessation interventions. Int J Environ Res Public Health (2008) 0.77
Searching for COPD: are questionnaires the answer? COPD (2010) 0.77
The effect of mold sensitization and humidity upon allergic asthma. Clin Respir J (2012) 0.77
Influenza vaccination coverage among adults with asthma: findings from the 2000 Behavioral Risk Factor Surveillance System. Am J Med (2004) 0.77
Weight-loss practices and asthma: findings from the behavioral risk factor surveillance system. Obes Res (2003) 0.77
Reducing COPD readmissions: great promise but big problems. Chest (2015) 0.77
Role of Stress and Smoking as Modifiable Risk Factors for Nonpersistent and Persistent Back Pain in Women. Clin J Pain (2016) 0.76
COPD as a disease of children: hype or hope for better understanding? Thorax (2010) 0.76
Obstructive lung disease models: what is valid? COPD (2008) 0.76
Is vitamin D's "moment in the sun" behind us? Chest (2014) 0.76
Looking beyond the cigarette in COPD. Chest (2008) 0.76
COPD and lung cancer among women: an equal opportunity risk? J Thorac Oncol (2009) 0.75
Should we be using statistics to define disease? Thorax (2008) 0.75